Efficacy and safety of treatment of hypertensive patients with fixed combination perindopril/indapamide up to 102.5mg: Results of the FALCO FORTE programme

High Blood Pressure and Cardiovascular Prevention

Volumn 18, Issue 3, 2011, Pages 107-113

  Pella, Daniel ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

combination treatment; hypertension; indapamide; perindopril

Indexed keywords

ANTIHYPERTENSIVE AGENT; INDAPAMIDE PLUS PERINDOPRIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRY COUGH; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; QUALITY OF LIFE; SHIVERING; SIDE EFFECT; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; UREA BLOOD LEVEL;

AGED; ANALYSIS OF VARIANCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; DIURETICS; DRUG COMBINATIONS; FEMALE; HUMANS; HYPERTENSION; INDAPAMIDE; MALE; MIDDLE AGED; PERINDOPRIL; PROSPECTIVE STUDIES; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTORS; SLOVAKIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 80053411342     PISSN: 11209879     EISSN: 11791985     Source Type: Journal    
DOI: 10.2165/11593520-000000000-00000     Document Type: Article

References (22)

1. Sninčák M, Balažovjech I, Machá čová E, et al. Epidemiológia artériovej hypertenzie na Slovensku. Intern Med 2006; 6: 3-26
2. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996 May 22-29; 275 (20): 1571-6 (Pubitemid 26154243)
3. Assmann G, Schulte H. The Prospective Cardiovascular Munster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J 1988 Dec; 116 (6 Pt 2): 1713-24 (Pubitemid 19015651)
4. Lloyd-Jones DM, Evans JC, Larson MG, et al. Treatment and control of hypertension in the community: a prospective analysis. Hypertension 2002 Nov; 40 (5): 640-6 (Pubitemid 35278599)
5. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003 May 21; 289 (19): 2560-72 (Pubitemid 37430158)
6. Pella D, Fedacko J, Rybar R, et al. The reduction of total cardiovascular risk: results of theSTRONG DUETstudy [abstract]. Eur JCardiovasc Prev Rehab 2009; 16 Suppl. 1: S105
7. Pella D. Cardiovascular risk stratification and evidence based medicine hypertension treatment: results of the scientific programme FALCO. Intern Med 2009; 9 (1): 39-46
8. Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2000 summary. Adv Data 2002 Jun 5; 328: 1-32
9. Mancia G, Grassi G. Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens 2002 Aug; 20 (8): 1461-4 (Pubitemid 34921162)
10. Basile J. Blood pressure responder rates versus goal rates: which metric matters? Ther Adv Cardiovasc Dis 2009 Apr; 3 (2): 157-74
11. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007 Jun; 25 (6): 1105-87 (Pubitemid 46924065)
12. Moser M, Cushman WC, Kaplan NM. Control of blood pressure: does it matter which agent you use? J Clin Hypertens (Greenwich) 2007 Dec; 9 (12): 964-73
13. Pella D. Effective systolic blood pressure control by fixed low-dose combination of antihypertensive drugs: results of the scientific programme PROGRESSIVE. Intern Med 2007; 7 (4): 217-23
14. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008 May 1; 358 (18): 1887-98 (Pubitemid 351620109)
15. Kostis JB. Treating hypertension in the very old.NEngl JMed 2008 May 1; 358 (18): 1958-60 (Pubitemid 351620118)
16. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001 Sep 29; 358 (9287): 1033-41
17. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011 Jan; 42 (1): 227-76
18. Nishioku T, Takata F, Yamauchi A, et al. Protective action of indapamide, a thiazide-like diuretic, on ischemia-induced injury and barrier dysfunction in mouse brain microvascular endothelial cells. J Pharmacol Sci 2007 Mar; 103 (3): 323-7 (Pubitemid 46465776)
19. Dahlöf B, Gosse P, Gueret P, et al. Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study. J Hypertens 2005 Nov; 23 (11): 2063-70 (Pubitemid 41830403)
20. Mogensen CE, Viberti G, Halimi S, et al. Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression - PREMIER. Hypertension 2003 May; 41 (5): 1063-71 (Pubitemid 36548604)
21. Patel A, MacMahon S, Chalmers J, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomized controlled trial. Lancet 2007 Sep 8; 370 (9590): 829-40 (Pubitemid 47362321)
22. Mancia G, Grassi G. Protection of patients with diabetes, with or without hypertension: implications of ADVANCE for clinical practice. J Hypertens Suppl 2009 May; 27 (1): S19-23